Clinical Associate Professor of Internal Medicine
[email protected]
Available to mentor
Monalisa Ghosh
Clinical Associate Professor
-
Center MemberRogel Cancer Center
-
Nanavaty R, Choquet S, Ghosh M, Orciuolo E, vahi RD, Wahlstrom J, You X, Zhang S, Schonberg D, Prockop S. Clinical Lymphoma Myeloma & Leukemia, 2024 Sep; 24: s606Journal ArticleCT-439 Clinical Experience of Tabelecleucel in Epstein–Barr Virus-Positive Posttransplant Lymphoproliferative Disease (EBV+ PTLD) Involving the Central Nervous System
DOI:10.1016/s2152-2650(24)01778-6 -
Baiocchi R, Choquet S, Ghosh M, Orciuolo E, Dinavahi R, Wahlstrom J, You X, Zhang S, Schonberg D, Prockop S. Clinical Lymphoma Myeloma & Leukemia, 2024 Sep; 24: s252Journal ArticleClinical Experience of Tabelecleucel in Epstein–Barr Virus-Positive Posttransplant Lymphoproliferative Disease (EBV+ PTLD) Involving the Central Nervous System
DOI:10.1016/s2152-2650(24)01058-9 -
Schuster SJ, Fowler NH, Dickinson M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Pérez-Simón JA, Chen AI, Nastoupil LJ, von Tresckow B, Ferreri AJM, Teshima T, Patten PEM, McGuirk JP, Petzer AL, Offner F, Viardot A, Zinzani PL, Malladi R, Zia A, Awasthi R, Paule I, Germano D, Ramos R, Hsu P, Thieblemont C, Dreyling M. Clinical Lymphoma Myeloma & Leukemia, 2024 Sep; 24: s222Journal ArticleClinical Outcomes of Patients With Relapsed/Refractory Follicular Lymphoma (R/R FL) Treated With Tisagenlecleucel: Phase 2 ELARA 3-Year Follow- Up
DOI:10.1016/s2152-2650(24)00855-3 -
Schuster SJ, Fowler NH, Dickinson M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Pérez-Simón JA, Chen AI, Nastoupil LJ, von Tresckow B, Ferreri AJM, Teshima T, Patten PEM, McGuirk JP, Petzer AL, Offner F, Petzer AL, Patten PEM, Malladi R, Zia A, Awasthi R, Paule I, Germano D, Ramos R, Hsu P, Thieblemont C, z-Lopez M. Clinical Lymphoma Myeloma & Leukemia, 2024 Sep; 24: s495 - s496.Journal ArticleIBCL-271 Clinical Outcomes of Patients With Relapsed/Refractory Follicular Lymphoma (R/R FL) Treated With Tisagenlecleucel: Phase 2 ELARA 3-Year Follow-Up
DOI:10.1016/s2152-2650(24)01561-1 -
Dreyling M, Fowler NH, Dickinson M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Pérez-Simón JA, Chen AI, Nastoupil LJ, von Tresckow B, María Ferreri AJ, Teshima T, Patten PEM, McGuirk JP, Petzer AL, Offner F, Viardot A, Zinzani PL, Malladi R, Paule I, Zia A, Awasthi R, Han X, Germano D, O'Donovan D, Ramos R, Maier HJ, Masood A, Thieblemont C, Schuster SJ. Blood, 2024 Apr 25; 143 (17): 1713 - 1725.Journal ArticleDurable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.
DOI:10.1182/blood.2023021567 PMID: 38194692 -
Flora C, Olesnavich M, Zuo Y, Sandford E, Madhukar R, Rozwadowski M, Sugur K, Ly A, Canbaz AA, Shedeck A, Li G, Geer MJ, Yanik GA, Ghosh M, Frame DG, Bonifant CL, Jain T, Knight JS, Choi SW, Tewari M. Blood Adv, 2024 Mar 26; 8 (6): 1422 - 1426.Journal ArticleLongitudinal plasma proteomics in CAR T-cell therapy patients implicates neutrophils and NETosis in the genesis of CRS.
DOI:10.1182/bloodadvances.2023010728 PMID: 38266157 -
Bajwa A, Zhao Q, Geer MJ, Mian A, Lin C, Frame D, Westholder J, Tossey J, Ghosh M, Galal A, Ahmed N, Maakaron JE, Denlinger N, de Lima M, Epperla N, Caimi P, Voorhees T. Transplantation and Cellular Therapy, 2024 Feb; 30 (2): s201 - s202.Journal ArticleEfficacy of Siltuximab for Chimeric Antigen Receptor T-Cell Therapy Toxicities – a Multicenter Retrospective Analysis
DOI:10.1016/j.jtct.2023.12.261 -
Whalen M, Hayes C, Braun T, Myers D, Magenau J, Maciejewski J, Anand S, Riwes MM, Abusin G, Vander Lugt MT, Ghosh M, Pawarode A, Choi S, Triebwasser M, Yanik GA. Transplantation and Cellular Therapy, 2024 Feb; 30 (2): s118Proceeding / Abstract / PosterIncidence of Restrictive Lung Disease Following Autologous Stem Cell Transplantation for High Risk Lymphoma
DOI:10.1016/j.jtct.2024.01.004
Health Lab
Here, Monalisa Ghosh, M.D., a hematologist-oncologist at the University of Michigan Health Rogel Cancer Center, answers questions about cellular therapy; how it's used and what exciting developments are soon to come.
